Gulf Today has published a piece with a headline that cuts straight to the problem: "Your AI says you need fillers. Your AI has never touched a face." The framing matters for anyone running an aesthetic practice in 2025, because it names the exact fault line now opening between algorithm-generated treatment plans and the physical exam that injectable work has always depended on.

The source is an opinion column, not a trial readout, so there are no PASI scores or injector cohorts to parse here. What it offers instead is a practitioner-facing tension worth taking seriously. An AI tool can look at a photo, run it against a training set, and output "you need 1 mL of hyaluronic acid in the mid-face." It cannot palpate the malar fat pad. It cannot feel suppleness, assess vascular risk by hand, or notice the asymmetry that only shows up when the patient animates.

What does this change for clinics?

In practice, probably your intake conversation. Patients increasingly arrive with AI-generated self-diagnoses and pre-selected treatment menus. That shift lands on the person holding the syringe, not the vendor of the model. Your consultation now has to reconcile what a screen told the patient with what your hands and clinical judgment tell you.

The column's core argument, reduced to its sharpest form, is that filler recommendation is an act of physical assessment. Volume deficit, skin quality, and structural support are three-dimensional findings. A photograph is a two-dimensional proxy, and an AI trained on photographs inherits every limitation of that proxy.

Where the risk actually sits

A few practical implications follow for anyone in medical aesthetics:

• Recommendations generated without palpation or in-person exam skip the safety layer that catches vascular anatomical variation before injection, not after.
• Patient expectations get anchored before the consult, which makes informed-consent conversations harder, not easier.
• Liability stays with the injecting clinician. No algorithm shares it.
• Manufacturers and app developers can frame AI suggestions as convenience; clinics carry the clinical weight when those suggestions meet a real face.

That last point deserves emphasis. When an unexamined AI recommendation and a licensed injector disagree, the patient may hear the injector as the upsell and the algorithm as the neutral expert. Reversing that assumption is now part of the job.

Not an argument against AI

Nothing in the source suggests AI has no place in aesthetics. Image analysis already supports lesion tracking and skin-cancer screening pathways elsewhere in dermatology. The columnist's objection is narrower and more specific: a filler plan is a hands-on clinical judgment, and handing it to a system that has literally never touched a face moves it out of the domain where it belongs.

The reasonable middle ground most practices will land on looks like this: AI as a triage or education layer, the clinician as the decision layer, and no filler placed on the strength of an algorithm alone.

Watch this space. As AI beauty tools move from novelty to default consumer behavior, expect regulators and specialty societies to weigh in on where algorithmic advice ends and the physical exam legally begins — and clinics that set their own policy first will face fewer awkward consults when that line gets drawn.